Literature DB >> 17064641

Vulvar vestibulitis syndrome.

Carolyn Gardella1.   

Abstract

Vulvar vestibulitis syndrome (VVS) is one of the most common causes of genital pain and pain with sexual intercourse, affecting up to 15% of women. The syndrome is characterized by severe pain on vestibular touch or attempted vaginal entry, exquisite tenderness to palpation with a cotton swab, and often subtle physical findings confined to vestibular erythema. The etiology of VVS is unknown. However, it is probably best to consider VVS as a chronic local inflammatory condition with a wide variety of etiologic causes. The heterogeneity of potential etiologies for VVS results in the use of multiple treatment regimens in clinical practice. Scientifically rigorous studies are sorely needed to determine the best treatment approach.

Entities:  

Year:  2006        PMID: 17064641     DOI: 10.1007/s11908-006-0022-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.663


  59 in total

1.  A randomized comparison of group cognitive--behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis.

Authors:  Sophie Bergeron; Yitzchak M Binik; Samir Khalifé; Kelly Pagidas; Howard I Glazer; Marta Meana; Rhonda Amsel
Journal:  Pain       Date:  2001-04       Impact factor: 6.961

Review 2.  Vulvar vestibulitis syndrome: an overview.

Authors:  S C Marinoff; M L Turner
Journal:  Am J Obstet Gynecol       Date:  1991-10       Impact factor: 8.661

3.  A deficiency in interferon-alpha production in women with vulvar vestibulitis.

Authors:  Stefan Gerber; Ann Marie Bongiovanni; William J Ledger; Steven S Witkin
Journal:  Am J Obstet Gynecol       Date:  2002-03       Impact factor: 8.661

4.  Dysesthetic ("essential") vulvodynia. Treatment with amitriptyline.

Authors:  M McKay
Journal:  J Reprod Med       Date:  1993-01       Impact factor: 0.142

5.  Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro.

Authors:  S Santtila; K Savinainen; M Hurme
Journal:  Scand J Immunol       Date:  1998-03       Impact factor: 3.487

6.  Pure versus complicated vulvar vestibulitis: a randomized trial of fluconazole treatment.

Authors:  J Bornstein; G Livnat; Z Stolar; H Abramovici
Journal:  Gynecol Obstet Invest       Date:  2000       Impact factor: 2.031

7.  Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome.

Authors:  Caroline F Pukall; Yitzchak M Binik; Samir Khalifé; Rhonda Amsel; Frances V Abbott
Journal:  Pain       Date:  2002-03       Impact factor: 6.961

8.  Vulvar vestibulitis syndrome: an exploratory case-control study.

Authors:  S Bazin; C Bouchard; J Brisson; C Morin; A Meisels; M Fortier
Journal:  Obstet Gynecol       Date:  1994-01       Impact factor: 7.661

9.  Hypersensitivity to vaginal candidiasis or treatment vehicles in the pathogenesis of minor vestibular gland syndrome.

Authors:  S C Marinoff; M L Turner
Journal:  J Reprod Med       Date:  1986-09       Impact factor: 0.142

10.  Treatment of vulvar vestibulitis syndrome with electromyographic biofeedback of pelvic floor musculature.

Authors:  H I Glazer; G Rodke; C Swencionis; R Hertz; A W Young
Journal:  J Reprod Med       Date:  1995-04       Impact factor: 0.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.